Lumbar Spine Degeneration

6

Review clinical trials related to Lumbar Spine Degeneration. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)

The objective of this study is to evaluate the safety and effectiveness of LDGraft (investigational device) compared to 100% human tissue product allograft bone (control) when applied in an ALIF procedure in the treatment of patients with lumbar degenerative disc disease (DDD).

Participants needed: 40
Trial details
Phase: Phase 1, Phase 2Age: 22-80Biological sex: AllType: InterventionalSponsor: Locate Bio Pty LtdUpdated: May 27, 2026Locations: 3
Eligibility criteria

Skeletally mature adults ≥22 and ≤80 years at the time of surgery [+11]

Previous lumbar spine instrumentation (i.e., anterior disc replacement, interspi... [+21]

Status: Recruiting

The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

The purpose of this single-blind, randomized, controlled study is to assess the efficacy of "informative text messages" vs "traditional handouts" provided to lumbar spine surgery patients post-operatively.

Participants needed: 224
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Duke UniversityUpdated: May 8, 2026Locations: 1
Eligibility criteria

Primary lumbar fusion 1-4 levels [+6]

Prior lumbar fusions [+5]

Status: Recruiting

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

Participants needed: 140
Trial details
Phase: Phase 4Age: 18-75Biological sex: AllType: InterventionalSponsor: University of Southern CaliforniaUpdated: May 1, 2026Locations: 1
Eligibility criteria

degenerative lumbar disease [+2]

currently use a sleep aid nightly [+6]

Status: Recruiting

OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults

The proposed research is an important extension of an ongoing perioperative personalized analgesia and intravenous opioid pharmacogenetic research. This research focuses on two of the most commonly used oral opioid analgesics, oxycodone, and methadone, in adults following lumbar spinal fusion and decompression surgery. Genetic signature and combinatorial pharmacogenetic approaches perform better than single-gene associations. This innovative translational research will for the first time evaluate simultaneously the effects of multiple genes and interactions on oxycodone and methadone's pharmacokinetics and optimal clinical dosing and on its safety and efficacy in the highly vulnerable pediatric population. This research's multigenetic signature findings can be easily extrapolated to adults undergoing surgery or using oxycodone and/or methadone for chronic and cancer pain and in identifying opioid abusers at risk of severe respiratory depression and death. When methadone is given in addition to oxycodone for inpatient pectus excavatum repair and idiopathic scoliosis spinal fusions according to new departmental protocols, methadone pharmacokinetics and pharmacodynamics will also be evaluated.

Participants needed: 235
Trial details
Age: 18-99Biological sex: AllType: ObservationalSponsor: OpalGenix, IncUpdated: May 1, 2025Locations: 3
Eligibility criteria

>18 years of age [+2]

Children (<18 years of age) [+8]

Status: Not yet recruiting

Artificial Intelligence Enabled Decision Support for Selection of Patients for Lumbar Spine Surgery

Background One third of patients operated for lumbar disc herniation (LDH) or spinal stenosis (LSS) do not achieve substantial improvement. Studies indicate that well informed shared decision making (SDM) can improve the selection to surgery, and thus the outcomes. Numerous algorithms for outcome prediction have therefore been developed, and some use artificial intelligence (AI). Most are trained on small datasets, few are accurate, all are stand-alone or web-based applications not integrated in the electronic health record (EHR), and none are implemented in routine clinical practice. The Norwegian registry for spine surgery (NORspine) comprises a cohort of more than 69,000 cases. The investigators have used AI to analyze the dataset and predict the outcome, and developed a decision support tool (DST) which is seamlessly integrated in the EHR DIPS Arena®. The investigators intend to use the tool to inform the SDM between surgeons and patients about the indication for surgery (yes or no), to increase the proportion with a successful outcome. The aim of the study is to assess the safety and feasibility of the DST for use in a subsequent pilot study. The device The DST (the device) is an integrate compound of software-solutions. Baseline data are registered by patients and surgeons on questionnaires integrated in DIPS Arena®, and transferred to NORspine. The data are also transferred (de-identified) to the AI-enabled prediction algorithm which operates in a cloud-based model hosting service. The algorithm has been trained and validated on a dataset from NORspine. The area under the curve for prediction of the main outcome (Oswestry disability index after12 months) in receiver operating characteristic analysis is very high (0.85) for LDH and moderate (0.72) for LSS. The model host also calculates outcomes (proportions with substantial, slight, or no improvement, and worsening) for the 50 cases with baseline variables most similar to the present case ("patients-like-me"). Finally, the individual prediction and the outcomes for the "patients-like-me" are transferred back and displayed in the regular user interface of DIPS Arena® for use in the SDM. Clinical investigations For this feasibility study, the investigators will use convergent qualitative and quantitative mixed methods. The comparator is decision making in routine clinical practice, without use of the DST. The study will include 20 patients with magnetic resonance imaging confirmed LDH or LSS referred for evaluation of the indication for surgery, and six surgeons who do the evaluations. The study will iteratively redesign the user interface of the DST until it is considered safe and feasible for use in a following pilot study.

Participants needed: 26
Trial details
Age: 18-100Biological sex: AllType: InterventionalSponsor: University Hospital of North NorwayUpdated: Feb 4, 2025Locations: 1
Eligibility criteria

Patients with MRI-confirmed LDH or LSS referred to University hospital of North... [+1]

Patients unable to consent because of [+7]

Status: Recruiting

Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial

Symptomatic lumbar spinal stenosis is the most common indication for spinal surgery. However, more than one-third of the patients undergoing surgery for lumbar stenosis report dissatisfaction with the results. On the other hand, conservative treatment has shown positive results in some cases. This trial will compare the outcomes of surgical versus non-surgical treatment for lumbar stenosis.

Participants needed: 200
Trial details
Age: 50-85Biological sex: AllType: InterventionalSponsor: University of Roma La SapienzaUpdated: Feb 12, 2024Locations: 1
Eligibility criteria

Age 50-85 years. [+3]

Degenerative deformity with Cobb angle >20°. [+7]